Quick Answer
aTYR PHARMA INC reported Stockholders Equity of $67.48 million for fiscal year 2025.
aTYR PHARMA INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $67.48M | -3.6% |
| 2024 | $70.02M | -22.8% |
| 2023 | $90.66M | +26.9% |
| 2022 | $71.46M | -34.6% |
| 2021 | $109.30M | +245.3% |
| 2020 | $31.65M | +49.4% |
| 2019 | $21.19M | -37.0% |
| 2018 | $33.65M | -47.6% |
| 2017 | $64.25M | +2.3% |
| 2016 | $62.80M | -45.4% |
| 2015 | $115.05M | +226.4% |
| 2014 | -$91.01M | -37.7% |
| 2013 | -$66.08M | -2.4% |
| 2012 | -$64.55M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $80.23M | +22.8% | +7.2% |
| June 30, 2025 | $74.84M | -8.3% | -0.3% |
| March 31, 2025 | $75.05M | -11.1% | +7.2% |
| December 31, 2024 | $70.02M | -22.8% | +7.2% |
| September 30, 2024 | $65.33M | -33.6% | -20.0% |
| June 30, 2024 | $81.61M | -23.2% | -3.4% |
| March 31, 2024 | $84.47M | -23.1% | -6.8% |
| December 31, 2023 | $90.66M | +26.9% | -7.9% |
- aTYR PHARMA INC showed a decrease of -3.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, aTYR PHARMA INC’s stockholders equity has grown by 204.5% (from -$64.55 million to $67.48 million).
- The most recent figure is from aTYR PHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: